Rebound headaches

The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Causes

By Mayo Clinic staff

It's not clear why rebound headaches occur. However, scientists suspect that regular use of headache medications alters the way certain pain pathways and receptors work in the brain.

Rebound headaches can develop if you frequently use headache medication. Although the risk of developing medication-overuse headache varies depending on the medication, any acute headache medication has the potential to lead to rebound headaches, including:

  • Simple pain relievers. Common pain relievers such as aspirin and acetaminophen (Tylenol, others) may contribute to rebound headaches — especially if you exceed the recommended daily dosages. Pain relievers such as ibuprofen (Advil, Motrin, others) and naproxen (Aleve, others) are considered low risk for development of medication-overuse headache.
  • Combination pain relievers. Over-the-counter pain relievers that contain a combination of caffeine, aspirin and acetaminophen (Excedrin, others) are common culprits. This group also includes prescription medications such as Fioricet, Fiorinal and Esgic-Plus, which also contain the sedative butalbital. All of these medications are high risk for the development of medication-overuse headache. Some combination medications have even been withdrawn from the market in certain European countries.
  • Migraine medications. Various migraine medications have been linked with rebound headaches, including triptans (Imitrex, Zomig, others) and certain ergots — such as ergotamine (Ergomar, others). These medications have a moderate risk of causing medication-overuse headaches. Interestingly, the ergot dihydroergotamine (D.H.E. 45) appears to have a lower potential for leading to this problem.
  • Opiates. Painkillers derived from opium or from synthetic opium compounds include combinations of codeine and acetaminophen (Tylenol with Codeine No. 3 and No. 4, others). These medications are considered high risk for the development of rebound headaches.

Daily doses of caffeine — from your morning coffee, your afternoon soda, or any pain reliever or other product containing this mild stimulant — may fuel rebound headaches as well. Read product labels to make sure you're not wiring your system with more caffeine than you realize.

References
  1. Headache: Hope through research. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/headache/detail_headache.htm. Accessed Aug. 21, 2011.
  2. Evers S, et al. Clinical features, pathophysiology and treatment of medication overuse headaches. The Lancet Neurology. 2010;9:391.
  3. Cupini LM, et al. Medication overuse headache: Neurobiological, behavioural and therapeutic aspects. Pain. 2010;150:222.
  4. Bigal ME, et al. Overuse of acute migraine medications and migraine chronification. Current Pain and Headache Reports. 2009;13:301.
  5. Felice MD, et al. Update on medication-overuse headache. Current Pain and Headache Reports. 2011;15:79.
  6. Tepper SJ, et al. Breaking the cycle of medication overuse headache. Cleveland Clinic Journal of Medicine. 2010;77:236.
  7. Rapoport AM. Medication overuse headache: Awareness, detection and treatment. CNS Drugs. 2008;22:995.
  8. Sun-Edelstein C, et al. Alternative headache treatments: Nutraceuticals, behavioral and physical treatments. Headache Currents. 2011:469.
  9. Loder E, et al. Evaluation for secondary causes of headache: The role of blood and urine testing. Headache Currents. 2011:338.
DS00613 Dec. 9, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger